Timiperone

替米哌隆

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameTimiperone
Drug Alias Name替米呱隆timiperona硫米哌酮timiperonumTolopelon +[6
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine D2 receptor antagonists
TargetsDopamine D2 receptor
Therapy Area/IndicationsSchizophrenia
Global Approved IndicationsSchizophrenia
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date1983/09/21
Country/TerritoryJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsSchizophrenia
Inactive IndicationsN/A

Other Information

ATC CodeN05A
Related LinksWikipediaKEGG